Conference Coverage

Does medical marijuana work for PTSD, other psychiatric indications?


 

EXPERT ANALYSIS FROM THE ASCP ANNUAL MEETING

References

Dr. D’Souza reported a financial relationship with Insys Therapeutics, which develops pharmaceutical cannabinoid products.

koakes@frontlinemedcom.com

On Twitter @karioakes

Pages

Recommended Reading

FDA approves changing brand name of Brintellix to Trintellix
MDedge Psychiatry
Prompt antidepressant treatment swiftly chops cardiovascular risk
MDedge Psychiatry
Screen and treat MS patients for emotional distress, depression
MDedge Psychiatry
SSRIs don’t boost risk in patients with bleeding peptic ulcers
MDedge Psychiatry
Binge-eating disorder more common than thought, rarely diagnosed
MDedge Psychiatry
The scourge of societal anosognosia about the mentally ill
MDedge Psychiatry
How to control weight gain when prescribing antidepressants
MDedge Psychiatry
Advances in transcranial magnetic stimulation for managing major depressive disorders
MDedge Psychiatry
Weight gain and antidepressants
MDedge Psychiatry
Peter Kramer returns to his role in defending antidepressants in ‘Ordinarily Well’
MDedge Psychiatry